The purpose of this study is to compare the background regional cerebral blood flow (rCBF) in TIA patients with and without angiographically demonstrable lesions. 147 TIA patients with severe stenosis or occlusion of major vessels supplying the brain (A group) were compared with a similar group without any arterial lesion demonstrable by angiography (B group). Their rCBFs were measured by the intravenous Xe133 technique. The average of mean rCBF (MrCBF) in (A) group (119 cases) with a mean age of 59.9 yrs was 50.1 +/- 12.3 ml/100g/m and the average of MrCBF in (B) group (31 cases) with a mean age of 59.3 years was 47.6 +/- 11.8 ml/100g/m. In spite of no angiographic lesion in (B) group, the MrCBF was lower in value than that in (A) group. The average of hemispheric rCBF (HrCBF) was approximately the same bilaterally in a control group (55.4 ml/100g/m), and even in (B) group there was no significant difference between the symptomatic side and the non-symptomatic side. In (A) group, HrCBF on the symptomatic side (48.1 ml/100g/m) was significantly lower on the average than that on the opposite side (51.5 ml/100g/m). Comparing probe by probe in TIA patients, the average rCBF of the symptomatic site was 44.1 +/- 11.9 ml/100g/m and that of the symmetrically opposite site was 47.6 +/- 13.0 ml/100g/m in (A) group. In (B) group, the average rCBF of the symptomatic site was 46.2 +/- 10.8 ml/100g/m, and 47.7 +/- 10.8 ml/100g/m for the non-symptomatic site. These values in both group (A) and (B), have a significant difference between symptomatic probes and non-symptomatic probes (p less than 8.0 X 10(-7) and p less than 6.5 X 10(-3)).
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1080/01616412.1985.11739713 | DOI Listing |
Front Neurol
December 2024
Department of Neurosurgery, Ajou University Hospital, Ajou University School of Medicine, Suwon, Republic of Korea.
Objective: The optimal timing of bypass surgery for patients with moyamoya disease (MMD) or moyamoya syndrome (MMS) following an acute stroke episode remains unclear, mainly owing to the risk of postoperative complications. In this study, we aim to validate the safety and efficacy of early intervention using multiple burr hole (MBH) and erythropoietin (EPO) therapy, thereby refining the management strategy for patients with acute stroke episode of MMD or MMS.
Methods: We retrospectively analyzed data from 70 patients with MMD or MMS who underwent MBH and EPO therapy.
Curr Neurovasc Res
December 2024
Department of Neurology, West China Hospital, Sichuan University, Chengdu, PR China.
Objective: This study aimed to explore Malignant Brain Edema (MBE) and associated factors in patients with Large Hemispheric Infarction (LHI) following early reperfusion therapy.
Methods: We consecutively and retrospectively enrolled a cohort of 114 LHI patients who had received early reperfusion therapy, including Intravenous Thrombolysis (IVT) or Endovascular Therapy (EVT) at the hyperacute stage of stroke between January 2009 and December 2018. MBE was defined as a midline shift ≥5 mm, accompanied by signs of herniation.
J Atheroscler Thromb
December 2024
Department of Radiology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Shandong University.
Aim: This study assessed the predictive value of pericarotid fat density (PFD) on carotid computed tomography angiography (CTA) for recurrent ischemic stroke or transient ischemic attack (TIA).
Methods: In total, 739 patients who underwent CTA between January 2014 and December 2021 were retrospectively included in this study. The PFD was evaluated using carotid CTA.
Metab Brain Dis
January 2025
Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
In the acute stage of stroke, stress hyperglycemia is common in both diabetic and nondiabetic patients. The associations between stress hyperglycemia and functional outcomes, as well as stroke recurrence were heterogeneous in previous studies. We aimed to demonstrate these associations in a general population of patients with ischemic stroke and transient ischemic attack (TIA).
View Article and Find Full Text PDFSingapore Med J
January 2025
Department of Radiology, Armed Forces Institute of Radiology, Pakistan.
Introduction: We explored the efficacy and safety of dual antiplatelet therapy (DAPT) for individuals diagnosed with stroke or transient ischaemic attack (TIA), incorporating the latest insights from randomised controlled trials (RCTs). The emerging evidence surrounding DAPT in stroke and TIA plays a pivotal role in guiding clinical decisions.
Methods: Our study included five RCTs (INSPIRES, THALES, POINT, CHANCE, FASTER) on DAPT (aspirin + P2Y12 inhibitor) initiated within 72 hours of acute stroke or TIA, which evaluated DAPT efficacy and safety over 21-90 days, focusing on new strokes and major bleeding.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!